Articles by Hellen Berger - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Hellen Berger
12
Next »

Report from Brazil

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.
May 2, 2013
By: Hellen Berger

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Report from Brazil

Brazil's major vaccine producer innovates with stem-cell research.
Mar 2, 2013
By: Hellen Berger

Brazil's major vaccine producer innovates with stem-cell research.

Report from Brazil

Brazil to locally produce HIV/AIDS antiretroviral drug atazavanir.
Jan 1, 2013
By: Hellen Berger

The health ministry of Brazil recently signed an agreement to obtain its production technology to locally develop the antiretroviral drug atazavanir sulfate.

Report from Brazil

Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.
Sep 2, 2012
By: Hellen Berger

Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.

Report from Brazil

Brazil's generic-drug market is growing steadily.
Mar 2, 2012
By: Hellen Berger

Brazil's generic-drug market is growing steadily.

Report from Latin America

Growth and change in Brazil and Mexico offer key opportunities for the region's pharmaceutical industry.
Sep 2, 2011
By: Hellen Berger

Growth and change in Brazil and Mexico offer key opportunities for the region's pharmaceutical industry.

Report From Brazil

Brazil develops its first national plasma fractionation plant.
Mar 2, 2011
By: Hellen Berger

Brazil develops its first national plasma fractionation plant.

Report from Brazil

A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.
Sep 2, 2010
By: Hellen Berger

A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.

Report from Brazil

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?
May 2, 2010
By: Hellen Berger

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?

12
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here